inhaler medication

Flovent disappeared Jan. 1, when GSK pulled it. Insurers dropping coverage and Medicaid rule changes likely incentivized the move to protect profits.

GSK plans to sell generic versions of the inhalers, but many are still worried about insurance coverage for alternatives.